Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by BearDownAZon Sep 26, 2020 12:29pm
194 Views
Post# 31625353

RE:More Analyst Coverage coming?

RE:More Analyst Coverage coming?Yeah I saw that on Zacks the other day too when I was looking to see if there was a new Resverlogix report. He previously did the analyst reports for Resverlogix, but Resverlogix is no longer listed in the company's he covers. Though Resverlogix still has him listed as one of their analysts on their company webpage. Anyways, it will be interesting to see their first report on Bioasis. No report posted yet.

BDAZ
<< Previous
Bullboard Posts
Next >>